Potential risk of adverse event in patients undergo elective urologic surgery



Ratih Wulansari Ratih Wulansari(1*)

(1) 
(*) Corresponding Author

Abstract


Background: Almost all medical treatment may pose risk. The risk of adverse event in patients undergoing surgery is higher than those who undergo non surgical intervention. The incidence of adverse event varies from 3.7% in the US to 16.7% in Australia. Basically, most of the adverse events are preventable. It is therefore recommended to implement clinical risk management in health care services. Objective: To identify risk of adverse event among patients undergo elective urologic surgery

Method: A cross sectional study was carried out to collect prospective data on patients underwent elective urologic surgery at Tabanan General Hospital between August-September 2005. Data on the risk of adverse event were identified since patients were admitted to Hospital, underwent pre-op preparation and surgical procedure. Follow up was carried out until 30 days after surgical procedure

Result: Seven major potential risks were identified, i.e.(1) pre-operative stay> 3 days (28.85%);(2) patients' risks for surgery (44.23%); (3) prophylactic antibiotic were given > 2 hours before surgery (88.46%); (4) ASA > (82.69%); (5) preoperative hair removal > 2 hours before surgery (86.53%); (6) use of intravenous line more than 24 hours (26.92%); and (7) use of urine cathether > 6 days (25%). It is found that pre-operative stay > 3 days was significantly related to the occurrence of adverse event.

Conclusion: Pre-operative stay > 3 days contributed significantly in the occurrence of adverse event among patients underwent elective urologic surgery. However, other risk factors were not significantly related to adverse event due to small sample size.

Key words: elective urologic surgery - risk - clinical risk management - clinical governance

 






Article Metrics

Abstract views : 593 | views : 1839




Copyright (c) 2015 Ratih Wulansari Ratih Wulansari

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.